These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor. Coplen DE, Marcus MD, Myers JA, Ratliff TL, Catalona WJ. J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321 [Abstract] [Full Text] [Related]
17. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WR, Whitmore WF. J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949 [Abstract] [Full Text] [Related]
18. Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C. Soloway MS, Perry A. J Urol; 1987 May; 137(5):871-3. PubMed ID: 3106653 [Abstract] [Full Text] [Related]